Evidence map›Paper›PMID 21296624›Full record

SynthesisDNA repair2011

An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.

Hongping Yu, Hui Zhao, Li-E Wang, Younghun Han, Wei V Chen, Christopher I Amos, Thorunn Rafnar, Patrick Sulem, Kari Stefansson, Maria Teresa Landi and 9 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in DNA repair, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Statistical Inference for Cox Proportional Hazards Models with a Diverging Number of Covariates.Scandinavian journal of statistics, theory and applications · 2023
    Article
  5. A Decade of GWAS Results in Lung Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Polymorphisms in MicroRNAs are associated with survival in non-small cell lung cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
  12. DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial.International journal of molecular epidemiology and genetics · 2013
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 4 countries.

Hongping YuDepartment of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Hui Zhao
Li-E Wang
Younghun Han
Wei V Chen
Christopher I Amos
Thorunn Rafnar
Patrick Sulem
Kari Stefansson
Maria Teresa Landi
Neil Caporaso
Demetrius Albanes
Michael Thun
James D McKay
Paul Brennan
Yufei Wang
Richard S Houlston
Margaret R Spitz
Qingyi Wei
The University of Texas MD Anderson Cancer Center · USdeCODE Genetics (Iceland) · ISNational Institutes of Health · USCentre International de Recherche sur le Cancer · FRInstitute of Cancer Research · GBAmerican Cancer Society · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Molecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3M
ECOGENETIC STUDY OF LUNG CANCER IN MINORITIESR01CA055769 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 1991 to 2008
$5.3M
CLINICAL AND EPIDEMIOLOGIC CENTER FOR BIOMARKERS OF UPPEU01CA086390 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 2000 to 2004
$4.3M
High Density Association Analysis of Lung CancerR01CA121197 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2007 to 2010
$3.0M
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck CancerR01CA131274 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2009 to 2013
$3.0M
NCI NIH HHS CA121197NCI NIH HHS CA131274NCI NIH HHS CA 16672NCI NIH HHS CA55769NCI NIH HHS CA86390NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA055769NCI NIH HHS R01 CA121197NCI NIH HHS R01 CA131274NCI NIH HHS U01 CA086390NCI NIH HHS U19 CA148127NIEHS NIH HHS ES11740NIEHS NIH HHS R01 ES011740
6 · The paper itself

Abstract

DNA repair genes are important for maintaining genomic stability and limiting carcinogenesis. We analyzed all single nucleotide polymorphisms (SNPs) of 125 DNA repair genes covered by the Illumina HumanHap300 (v1.1) BeadChips in a previously conducted genome-wide association study (GWAS) of 1154 lung cancer cases and 1137 controls and replicated the top-hits of XRCC4 SNPs in an independent set of 597 cases and 611 controls in Texas populations. We found that six of 20 XRCC4 SNPs were associated with a decreased risk of lung cancer with a P-value of 0.01 or lower in the discovery dataset, of which the most significant SNP was rs10040363 (P for allelic test=4.89 x 10⁻⁴). Moreover, the data in this region allowed us to impute a potentially functional SNP rs2075685 (imputed P for allelic test=1.3 x 10⁻³). A luciferase reporter assay demonstrated that the rs2075685G>T change in the XRCC4 promoter increased expression of the gene. In the replication study of rs10040363, rs1478486, rs9293329, and rs2075685, however, only rs10040363 achieved a borderline association with a decreased risk of lung cancer in a dominant model (adjusted OR=0.80, 95% CI=0.62-1.03 and P=0.079). In the final combined analysis of both the Texas GWAS discovery and replication datasets, the strength of the association was increased for rs10040363 (adjusted OR=0.77, 95% CI=0.66-0.89, P(dominant)=5 x 10⁻⁴ and P for trend=5 x 10⁻⁴) and rs1478486 (adjusted OR=0.82, 95% CI=0.71-0.94, P(dominant)=6 x 10⁻³ and P for trend=3.5 x 10⁻³). Finally, we conducted a meta-analysis of these XRCC4 SNPs with available data from published GWA studies of lung cancer with a total of 12,312 cases and 47,921 controls, in which none of these XRCC4 SNPs was associated with lung cancer risk. It appeared that rs2075685, although associated with increased expression of a reporter gene and lung cancer risk in the Texas populations, did not have an effect on lung cancer risk in other populations. This study underscores the importance of replication using published data in larger populations.

Indexed as

Genome-Wide Association StudyPolymorphism, Single NucleotideAdultAgedCase-Control StudiesCell Line, TumorDNA-Binding ProteinsDNA RepairDNA ReplicationFemaleGenes, ReporterGenetic Predisposition to DiseaseGenotypeHeLa CellsHumansLung NeoplasmsDNA-Binding ProteinsXRCC4 protein, human

Identifiers

PMID21296624
PMCPMC3062723
OpenAlexW2040413443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.